background image

Boehringer Ingelheim Clinical Trials

Find clinical trials for Boehringer Ingelheim. Search for Boehringer Ingelheim clinical trials in different cities and states across the United States.

Filter
Active & Responsive

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for
Diabetes Mellitus, Type 2, Hypertension,
Location: Halifax, Moncton, Methuen MA, Hamden CT, Quebec,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07064473

Phase3, Recruiting
New

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

for
Diabetic Macular Edema
Location: Glendale CA
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07553429

Phase1, Phase2, Recruiting

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

for
Solid Tumors
Location: New Haven CT, Hackensack NJ, Los Angeles CA
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT05471856

Phase1, Recruiting

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

for
Solid Tumours
Location: New Haven CT, New York NY, Fairfax VA, Tamarac FL,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06581432

Phase2, Recruiting

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

for
Kidney Disease, Chronic
Location: Halifax, Portsmouth NH, East Providence RI, Quebec,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06531824

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

for
Small Cell Lung Carcinoma, Neuroendocrine Neoplasms,
Location: The Bronx NY, New York NY, Baltimore MD, Richmond VA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT05882058

Phase2, Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: New Haven CT, Fairfax VA, Nashville TN, Iowa City IA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06324357

Phase1, Phase2, Recruiting

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

for
Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Location: Halifax, Moncton, East Providence RI, Boston MA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06238622

Phase3, Recruiting

A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood

for
Idiopathic Pulmonary Fibrosis
Location: The Woodlands TX
Sponsor: Boehringer Ingelheim

Sex: All

Age: 40+

Code: NCT06241560

Phase2, Recruiting

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

for
Chronic Kidney Disease
Location: Indianapolis IN, Minneapolis MN, Edmonton
Sponsor: Boehringer Ingelheim

Sex: All

Age: 2 - 17

Code: NCT07107945

Phase3, Recruiting